ACRV | NVO | VRTX | REGN | MRNA | SGEN | |
---|---|---|---|---|---|---|
Company Name | Acrivon Therapeutics, Inc. Common Stock | Novo Nordisk A/S | Vertex Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. | Moderna, Inc. | Seagen Inc. |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Market Cap | $270.78M | $563.06B | $109.10B | $105.53B | $44.96B | $43.15B |
Employees | 0.06K | 66.02K | 5.40K | 13.68K | 5.60K | 3.26K |
CEO | Dr. Peter Blume-Jensen M.D., Ph.D. | Mr. Lars Fruergaard Jorgensen | Dr. Reshma Kewalramani FASN, M.D. | Dr. Leonard S. Schleifer M.D., Ph.D. | Mr. Stephane Bancel | Mr. David R. Epstein B.Sc., M.B.A. |